Considering their millionaire-maker-like gains, investors are surely wondering which of these hot stocks is the better investment at the moment.
Axon Enterprise (AXON) shares soared Tuesday after the public safety technology company reported better-than-expected results and issued a rosy outlook.
Axon shares jumped after the TASER maker beat Wall Street's second-quarter estimates and hiked its guidance. The security solutions company also hiked guidance for the year, saying it now expects revenues of $2.65 billion to $2.73 billion.
AXON crushes Q2 expectations with 74% EPS growth and raises its 2025 outlook as TASER, body cam and software demand soars.
Axon Enterprise, Inc. (NASDAQ:AXON ) Q2 2025 Earnings Conference Call August 4, 2025 5:00 PM ET Company Participants Brittany Bagley - COO & CFO Erik Taylor Lapinski - Senior Director of Investor Relations Jeffrey C. Kunins - Chief Product Officer & CTO Joshua M.
While the top- and bottom-line numbers for Axon (AXON) give a sense of how the business performed in the quarter ended June 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Axon Enterprise (AXON) came out with quarterly earnings of $2.12 per share, beating the Zacks Consensus Estimate of $1.54 per share. This compares to earnings of $1.2 per share a year ago.
Get a deeper insight into the potential performance of Axon (AXON) for the quarter ended June 2025 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some of its key metrics.
Axon Enterprise (AXON) closed at $728.74 in the latest trading session, marking a -1.03% move from the prior day.
AXON's AI-powered tools like Draft One and Redaction Assistant are fueling surging growth in public safety tech.
Axon (AXON) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?